Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4<sup>CRBN</sup> Protein Degradation Axis
Cereblon (CRBN), a primary target of immune-modulatory imide drugs (IMiDs), functions as a substrate receptor in the CUL4-RBX1-DDB1-CRBN (known as CRL4<sup>CRBN</sup>) E3 ubiquitin ligase complex. Binding of IMiDs to CRBN redirects the CRL4<sup>CRBN</sup> E3 ubiquitin ligase to recruit or displace i...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI AG
2021-05-01
|
| Σειρά: | Pharmaceuticals |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.mdpi.com/1424-8247/14/6/512 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|